# Noel Hall

> Noel Hall is a seed investor backing Biotechnology and SaaS. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Total investments: 3
- Last investment: Jul 2021
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/noel-hall-a6b88/

Noel Hall is a seed investor focused on Biotechnology and SaaS. Noel Hall is the Director of Corporate of Wellcome Trust. He is a former Board Director, Co-founder, and President of Aspreva Pharmaceuticals Corp. He attended the University of London.

## Contacts

5 contacts available for Noel Hall: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/mr-noel-hall?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $2.5M–$5.5M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| SaaS | 1 | 33% |
| Genetics | 1 | 33% |
| Biopharma | 1 | 33% |
| Health Care | 1 | 33% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 67% |
| Angel | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Canada | 1 | 33% |
| United States | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Incisive Genetics | IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform. | $2.5M | Seed | Jul 12, 2021 | https://www.incisivegenetics.com/ |
| Epistemic AI | At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us. | $5.5M | Seed | Apr 06, 2021 | https://www.epistemic.ai |
| Incisive Genetics | IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform. | $376K | Angel | Sep 22, 2020 | https://www.incisivegenetics.com/ |

3 of 3 investments shown.

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [BDC Venture Capital](https://shizune.co/investors/profile/bdc-venture-capital) — VC Fund
- [Real Ventures](https://shizune.co/investors/profile/real-ventures) — VC Fund
- [Anges Quebec](https://shizune.co/investors/profile/anges-quebec) — VC Fund

## Featured in investor lists
- [Biotech Angel Investors](https://shizune.co/investors/biotech-angel-investors)
- [Health Care Angel Investors in Canada](https://shizune.co/investors/health-care-angel-investors-canada)
- [Biotech Angel Investors in Canada](https://shizune.co/investors/biotech-angel-investors-canada)
- [Medical Device Angel Investors](https://shizune.co/investors/medical-device-angel-investors)
- [Medical Device Angel Investors in Canada](https://shizune.co/investors/medical-device-angel-investors-canada)
- [Biotechnology Angel Investors in Canada](https://shizune.co/investors/biotechnology-angel-investors-canada)

## FAQ

### What does Noel Hall invest in?

Noel Hall invests primarily in Biotechnology, SaaS and Genetics startups, most often at Seed and Angel stage. Most of the 3 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Noel Hall's check size?

Noel Hall typically joins rounds of $2.5M–$5.5M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Noel Hall participates in.

### How do I contact Noel Hall?

Public channels for Noel Hall include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Noel Hall last invest?

The most recent investment recorded for Noel Hall closed in Jul 2021. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co